AstraZeneca to pay up to $2 billion to license cardiovascular drug
AstraZeneca on Monday said it will pay up to $2 billion to license a cardiovascular drug.
AstraZeneca on Monday said it will pay up to $2 billion to license a cardiovascular drug.
Most of her wealth comes from her cosmetics company, but she has built up quite a property portfolio.
Former New York City mayor Rudy Giuliani is racing against time and has slashed the price by nearly $1 million.
Tether is building a financial tool for the “people left behind” The stablecoin was created in 2014 by Brock Pierce, Reeve Collins, and Craig Sellers...
Global mining giant Rio Tinto PLC has expressed interest in buying Arcadium Lithium PLC, both companies confirmed Sunday.
Activist investor Starboard Value has taken a $1 billion stake in beleaguered drugmaker Pfizer Inc. and is seeking a turnaround, the Wall Street Journal reported...
Middle East tensions, the port strike and the Fed’s interest-rate outlook puts inflation front and center again for the U.S. stock market this week.
This summer, restaurants and many retailers who weren’t Walmart warned of a struggling consumer.
Whoever wins November’s presidential election will be faced with an immediate need to negotiate with Congress over what income-tax rates should look like after the...